PDCD1 and neoplasm: These results demonstrated that the combination treatment of AOH1996 and anti-PD1 not only inhibited the CSCs and metastasis of HNSCC but also enhanced tumor cell-intrinsic immune responses, highlighting its potential as a synergistic therapeutic strategy for HNSCC.